Skip to content

Clinical feasibility of Low dose protocol for computed tomography angiography with iterative reconstruction algorithm in pre-operative examination of anterolateral thigh perforator flap surgery

Clinical feasibility of Low dose protocol for computed tomography angiography with iterative reconstruction algorithm in pre-operative examination of anterolateral thigh perforator flap surgery - Clinical feasibility of Low dose protocol for CTA with ASIR in ALTPF

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300068024
Enrollment
Unknown
Registered
2023-02-03
Start date
2016-07-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe skin trauma of extremities

Interventions

A:Filtered Back-Projection algorithm with 120KV
B:Adaptivestatistical iterative reconstruction with 100KV
C:Adaptivestatistical iterative reconstruction with 80KV

Sponsors

Wuxi 9th People's Hospital Affiliated to Soochow Universit(Wuxi Orthopaedics Hospital)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Age between 15 and 70 years old; 2. BMI between 18-27 kg/m^2; 3. All patients had no history of hypersensitivity to contrast agents and serious medical diseases such as kidney disease. 4. In accordance with the indications of anterolateral femoral perforator flap transplantation; 5. All patients or family members signed informed consent forms.

Exclusion criteria

Exclusion criteria: 1. Allergic to contrast media; 2. Patients with serious internal diseases such as heart and kidney; 3. Patients with contraindications for anterolateral femoral perforator flap transplantation.

Design outcomes

Primary

MeasureTime frame
vessel attenuation value;the signal-to-noise ratio;the contrast-to-noise ratio;the figure of merit;the 4-point Likert Scale;

Secondary

MeasureTime frame
scan length;dose–length product;CT dose index;the effective dose;

Countries

China

Contacts

Public ContactYing Yang
wxyy0501@126.com+86 137 7105 8000

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026